These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15548573)

  • 1. Targeting leukocyte integrins in human diseases.
    Yonekawa K; Harlan JM
    J Leukoc Biol; 2005 Feb; 77(2):129-40. PubMed ID: 15548573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs.
    Hilden TJ; Nurmi SM; Fagerholm SC; Gahmberg CG
    Ann Med; 2006; 38(7):503-11. PubMed ID: 17101541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
    Danese S; Semeraro S; Marini M; Roberto I; Armuzzi A; Papa A; Gasbarrini A
    Dig Liver Dis; 2005 Nov; 37(11):811-8. PubMed ID: 16168725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.
    Ulbrich H; Eriksson EE; Lindbom L
    Trends Pharmacol Sci; 2003 Dec; 24(12):640-7. PubMed ID: 14654305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
    Van Assche G; Rutgeerts P
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease.
    Mitroulis I; Alexaki VI; Kourtzelis I; Ziogas A; Hajishengallis G; Chavakis T
    Pharmacol Ther; 2015 Mar; 147():123-135. PubMed ID: 25448040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions.
    Kaneider NC; Leger AJ; Kuliopulos A
    FEBS J; 2006 Oct; 273(19):4416-24. PubMed ID: 16956369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy.
    Norman MU; Kubes P
    Microcirculation; 2005; 12(1):91-8. PubMed ID: 15804977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.
    Stefanelli T; Malesci A; De La Rue SA; Danese S
    Autoimmun Rev; 2008 May; 7(5):364-9. PubMed ID: 18486923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical overview of leukocyte adhesion and migration: where are we now?
    Marshall D; Haskard DO
    Semin Immunol; 2002 Apr; 14(2):133-40. PubMed ID: 11978085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Woodside DG; Vanderslice P
    BioDrugs; 2008; 22(2):85-100. PubMed ID: 18345706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Participation of the adhesion molecules in the development of inflammatory response].
    Farsky SP; Mello SB
    Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(1):80-9. PubMed ID: 7481462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.
    Alghisi GC; Rüegg C
    Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update.
    Cesarini M; Fiorino G
    Expert Rev Clin Immunol; 2013 Apr; 9(4):301-6. PubMed ID: 23557266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin modulation and signaling in leukocyte adhesion and migration.
    Rose DM; Alon R; Ginsberg MH
    Immunol Rev; 2007 Aug; 218():126-34. PubMed ID: 17624949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes.
    Laudanna C; Alon R
    Thromb Haemost; 2006 Jan; 95(1):5-11. PubMed ID: 16543955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte integrins and their ligand interactions.
    Hyun YM; Lefort CT; Kim M
    Immunol Res; 2009 Dec; 45(2-3):195-208. PubMed ID: 19184539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
    Davenport RJ; Munday JR
    Drug Discov Today; 2007 Jul; 12(13-14):569-76. PubMed ID: 17631252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Adhesion Molecules: Therapeutic Targets for Inhibition of Inflammatory States.
    Allen S; Moran N
    Semin Thromb Hemost; 2015 Sep; 41(6):563-71. PubMed ID: 26322694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-adhesion therapy.
    Cornejo CJ; Winn RK; Harlan JM
    Adv Pharmacol; 1997; 39():99-142. PubMed ID: 9160114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.